Exelixis Announces EMA Acceptance of Marketing Authorization...

Nov 29, 2012 Full story: Freshnews

Exelixis, Inc. today announced the European Medicines Agency has accepted for review the Marketing Authorization Application for COMETRIQ for the proposed indication of treatment of progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer .

Full Story
dailyrx

Austin, TX

#1 Nov 30, 2012
Looking for more information on Cometriq? Here's a pharmacist's description: http://www.rxwiki.com/cometriq
jenas1

San Jose, CA

#2 Dec 13, 2012
We don't have the time to keep up with the current marketing trends. We are looking for a marketing firm grand rapids who is forward thinking. Any recommendations?

http://deksia.com/

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Health Discussions

Title Updated Last By Comments
Gay-rights group backs use of HIV-prevention pill 55 min Rudy 32
GOP governors don't see 'Obamacare' going away 1 hr mjjcpa 89
Elizabeth Taylor & Michael Jackson at Her Final... 2 hr goodvibrations 2
Get Rid of Herpes Naturally & Fast: Download PD... (Mar '14) 3 hr Sarahcox 6
Girl with Asperger Syndrome Performing Michael ... 4 hr An NFL Fan 60
Low Cost Dental Implants In Costa Rica Cut Into... (Dec '12) 4 hr RJ of Oregon 22
Dr Amarjit Gill: Extractions can be a straightf... 5 hr Gerald Vonberger 1

Health People Search

Addresses and phone numbers for FREE